Previous studies have shown that ATF5 expression is significantly upregulated in a variety of cancers, such as epithelial ovarian cancer, glioblastoma, pancreatic cancer and chronic myeloid leukemia (Figs. 3, 4A) [106–109]. The gene discussed is ATF5; the disease is cancer.